Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

NCT05320926 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05320926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05320926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Recruiting
Start date
July 26, 2022
Completion date
July 10, 2028
Enrollment
3,744 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease